Janka Teutschbein

Title: Janka Teutschbein: Innovator in Immunology

Introduction

Janka Teutschbein is a notable inventor based in Jena, Germany. He has made significant contributions to the field of immunology, particularly in the area of T cell activation and analysis. His work has implications for understanding immune responses and developing diagnostic tools.

Latest Patents

Janka Teutschbein holds one patent that focuses on the in-vitro use of specific in-vivo-target antigens for the selective activation, detection, and analysis of CD4 T cells. This invention reveals an immune reactivity characterized by the presence of antigen-specific T cells, which include a high percentage of memory T cells. The patent outlines a method, composition, and kit that utilize antigens such as Scw4, Pst1, Shm2, GliT, and TpiA or their fragments.

Career Highlights

Throughout his career, Janka has worked with prominent organizations, including Miltenyi Biotec and the Leibniz Institute for Natural Product Research and Infection Biology—Hans Knoll Institute. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Janka has collaborated with esteemed colleagues, including Alexander Scheffold and Petra Bacher, who is a woman. These collaborations have enriched his research and fostered innovation in his field.

Conclusion

Janka Teutschbein is a distinguished inventor whose work in immunology has the potential to enhance our understanding of immune responses. His contributions through patents and collaborations reflect his commitment to advancing scientific knowledge.